Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,961 | 46 | 79.6% |
| Travel and Lodging | $914.20 | 4 | 18.4% |
| Education | $99.99 | 1 | 2.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Bausch & Lomb, a division of Bausch Health US, LLC | $1,531 | 17 | $0 (2021) |
| Bausch & Lomb Americas Inc. | $506.77 | 4 | $0 (2024) |
| Genentech, Inc. | $491.18 | 4 | $0 (2024) |
| Mallinckrodt Hospital Products Inc. | $336.34 | 4 | $0 (2024) |
| Alcon Vision LLC | $334.24 | 5 | $0 (2023) |
| Astellas Pharma US Inc | $263.16 | 2 | $0 (2024) |
| Sight Sciences, Inc. | $247.88 | 2 | $0 (2022) |
| Amgen Inc. | $228.57 | 2 | $0 (2024) |
| Horizon Therapeutics plc | $206.40 | 2 | $0 (2023) |
| Genentech USA, Inc. | $149.87 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,254 | 10 | Genentech, Inc. ($386.18) |
| 2023 | $916.03 | 9 | Genentech USA, Inc. ($149.87) |
| 2022 | $629.17 | 5 | Bausch & Lomb Americas Inc. ($263.79) |
| 2021 | $2,157 | 26 | Bausch & Lomb, a division of Bausch Health US, LLC ($1,531) |
| 2020 | $19.20 | 1 | Aerie Pharmaceuticals, Inc. ($19.20) |
All Payment Transactions
51 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | Genentech, Inc. | Susvimo (Drug), Vabysmo | Food and Beverage | In-kind items and services | $95.00 | General |
| Category: Immunology and Ophthalmology | ||||||
| 11/20/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $98.92 | General |
| Category: IMMUNOLOGY | ||||||
| 11/13/2024 | Genentech, Inc. | Susvimo (Drug) | Food and Beverage | In-kind items and services | $141.18 | General |
| Category: Immunology and Ophthalmology | ||||||
| 10/18/2024 | Bausch & Lomb Americas Inc. | XIPERE (Drug) | Food and Beverage | In-kind items and services | $147.98 | General |
| Category: Ophthalmology | ||||||
| 08/01/2024 | Regeneron Pharmaceuticals, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $146.88 | General |
| Category: OPHTHALMOLOGY | ||||||
| 05/21/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $110.42 | General |
| Category: Inflammation/Rare Disease | ||||||
| 04/11/2024 | Genentech, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $150.00 | General |
| Category: Immunology and Ophthalmology | ||||||
| 04/04/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $145.39 | General |
| Category: Ophthalmology | ||||||
| 03/28/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $118.15 | General |
| Category: Inflammation/Rare Disease | ||||||
| 01/26/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Education | In-kind items and services | $99.99 | General |
| Category: IMMUNOLOGY | ||||||
| 12/14/2023 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $107.95 | General |
| Category: IMMUNOLOGY | ||||||
| 12/07/2023 | Alimera Sciences, Inc. | ILUVIEN (Drug) | Food and Beverage | Cash or cash equivalent | $120.00 | General |
| Category: OPHTHALMOLOGY | ||||||
| 12/01/2023 | Bausch & Lomb Americas Inc. | XIPERE (Drug) | Food and Beverage | In-kind items and services | $95.00 | General |
| Category: Ophthalmology | ||||||
| 11/04/2023 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $149.87 | General |
| Category: Immunology and Ophthalmology | ||||||
| 10/19/2023 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $88.90 | General |
| Category: TEPEZZA | ||||||
| 10/13/2023 | Alcon Vision LLC | Clareon (Device) | Food and Beverage | In-kind items and services | $24.07 | General |
| Category: Ophthalmology | ||||||
| 09/26/2023 | Astellas Pharma US Inc | — | Food and Beverage | In-kind items and services | $117.77 | General |
| 07/06/2023 | Genentech, Inc. | Vabysmo | Food and Beverage | In-kind items and services | $105.00 | General |
| 01/15/2023 | EyePoint Pharmaceuticals US, Inc. | YUTIQ (Drug) | Food and Beverage | In-kind items and services | $107.47 | General |
| Category: Chronic Non-infectious Posterior Segment Uveitis | ||||||
| 07/14/2022 | Bausch & Lomb Americas Inc. | enVista MX60 IOL (Device), STELLARIS, AMVISC PLUS | Food and Beverage | In-kind items and services | $175.55 | General |
| Category: Ophthalmology | ||||||
| 06/02/2022 | Sight Sciences, Inc. | OMNI(R) SURGICAL SYSTEM (US) (Device) | Food and Beverage | In-kind items and services | $130.57 | General |
| Category: Ophthalmology | ||||||
| 03/16/2022 | Bausch & Lomb Americas Inc. | enVista MX60 IOL (Device), SOFPORT AO, STELLARIS | Food and Beverage | In-kind items and services | $88.24 | General |
| Category: Ophthalmology | ||||||
| 03/10/2022 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $117.50 | General |
| Category: TEPEZZA | ||||||
| 01/13/2022 | Sight Sciences, Inc. | OMNI(R) SURGICAL SYSTEM (US) (Device) | Food and Beverage | In-kind items and services | $117.31 | General |
| Category: Ophthalmology | ||||||
| 11/23/2021 | Bausch & Lomb, a division of Bausch Health US, LLC | STELLARIS (Device) | Food and Beverage | In-kind items and services | $29.88 | General |
| Category: Ophthalmology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 218 | 259 | $73,244 | $14,433 |
| 2022 | 2 | 39 | 45 | $14,741 | $2,611 |
All Medicare Procedures & Services
11 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 34 | 48 | $18,288 | $3,654 | 20.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 24 | 24 | $11,274 | $2,668 | 23.7% |
| 92134 | Imaging of retina | Office | 2023 | 59 | 71 | $16,565 | $2,422 | 14.6% |
| 67028 | Injection of drug into eye | Office | 2023 | 17 | 18 | $11,229 | $1,724 | 15.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 18 | 21 | $4,515 | $1,553 | 34.4% |
| 67028 | Injection of drug into eye | Facility | 2023 | 11 | 13 | $4,604 | $890.50 | 19.3% |
| 92134 | Imaging of retina | Facility | 2023 | 32 | 38 | $3,474 | $658.00 | 18.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 11 | 11 | $1,540 | $507.43 | 33.0% |
| 92285 | Photography of content of eyes | Office | 2023 | 12 | 15 | $1,755 | $355.99 | 20.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 18 | 22 | $8,646 | $1,778 | 20.6% |
| 92134 | Imaging of retina | Office | 2022 | 21 | 23 | $6,095 | $833.12 | 13.7% |
About Dr. Akshay Mentreddy, DO
Dr. Akshay Mentreddy, DO is a Ophthalmology healthcare provider based in Winston Salem, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/27/2018. The National Provider Identifier (NPI) number assigned to this provider is 1538664008.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Akshay Mentreddy, DO has received a total of $4,975 in payments from pharmaceutical and medical device companies, with $1,254 received in 2024. These payments were reported across 51 transactions from 17 companies. The most common payment nature is "Food and Beverage" ($3,961).
As a Medicare-enrolled provider, Mentreddy has provided services to 257 Medicare beneficiaries, totaling 304 services with total Medicare billing of $17,044. Data is available for 2 years (2022–2023), covering 11 distinct procedure/service records.
Practice Information
- Specialty Ophthalmology
- Other Specialties Neurology, Student in an Organized Health Care Education/Training Program
- Location Winston Salem, NC
- Active Since 03/27/2018
- Last Updated 08/29/2023
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1538664008
Products in Payments
- STELLARIS (Device) $1,439
- enVista MX60 IOL (Device) $355.51
- ACTHAR (Biological) $336.34
- Vabysmo (Drug) $299.87
- OMNI(R) SURGICAL SYSTEM (US) (Device) $247.88
- XIPERE (Drug) $242.98
- Susvimo (Drug) $236.18
- TEPEZZA (Biological) $228.57
- TEPEZZA (Drug) $206.40
- Centurion (Device) $186.10
- EYLEA HD (Biological) $146.88
- Izervay (Drug) $145.39
- OXERVATE (Drug) $124.99
- DURYSTA (Drug) $124.11
- AcrySof IQ PanOptix (Device) $124.07
- ILUVIEN (Drug) $120.00
- YUTIQ (Drug) $107.47
- Clareon (Device) $24.07
- PIFELTRO (Drug) $20.27
- rhopressa (Drug) $19.20
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Winston Salem
Dr. Rajiv Shah, Md, MD
Ophthalmology — Payments: $951,661
Keith Walter, Md, MD
Ophthalmology — Payments: $722,167
Dr. Vishak John, M.d, M.D
Ophthalmology — Payments: $202,813
Charles Richards, Md, MD
Ophthalmology — Payments: $9,728
Margaret Greven, M.d, M.D
Ophthalmology — Payments: $7,794
Dr. Vickas Khemsara, Md, MD
Ophthalmology — Payments: $6,351